Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;70(6):711-4.
doi: 10.1111/all.12603. Epub 2015 Mar 18.

Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma

P Emmanouil  1 , S Loukides  2 , K Kostikas  2 , G Papatheodorou  3 , A Papaporfyriou  1 , G Hillas  1 , I Vamvakaris  4 , R Triggidou  4 , P Katafigiotis  4 , A Kokkini  5 , S Papiris  2 , N Koulouris  1 , P Bakakos  1
Affiliations

Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma

P Emmanouil et al. Allergy. 2015 Jun.

Abstract

Clara cell secretory protein (CC16) is associated with Th2 modulation. Surfactant protein D (SPD) plays an important role in surfactant homeostasis and eosinophil chemotaxis. We measured CC16 and SPD in sputum supernatants of 84 asthmatic patients and 12 healthy controls. In 22 asthmatics, we additionally measured CC16 and SPD levels in BAL and assessed smooth muscle area (SMA), reticular basement membrane (RBM) thickness, and epithelial detachment (ED) in bronchial biopsies. Induced sputum CC16 and SPD were significantly higher in patients with severe asthma (SRA) compared to mild-moderate and healthy controls. BAL CC16 and SPD levels were also higher in SRA compared to mild-moderate asthma. CC16 BAL levels correlated with ED, while SPD BAL levels correlated with SMA and RBM. Severity represented a significant covariate for these associations. CC16 and SPD levels are upregulated in SRA and correlate with remodeling indices, suggesting a possible role of these biomarkers in the remodeling process.

Keywords: asthma; clinical immunology; remodelling.

PubMed Disclaimer

Substances